Javascript must be enabled to continue!
Comparative Assessment of the Physicochemical Properties of Different Brands of Levothyroxine
View through CrossRef
Levothyroxine is an oral form of drug that is used for hypothyroidism disorder. Hypothyroidism disorder is a condition in which the gland does not produce enough thyroid hormones for the body to perform its functions effectively. In the commercial market, various brands of levothyroxine are available that are frequently prescribed for hypothyroidism. In this study, we determined the comparative assessment of physicochemical properties of different brands of marketed available levothyroxine oral tablets in Karachi, Pakistan. In this study, we evaluated the pharmaceutical equivalency of different marketed brands of levothyroxine by using QC parameters, i.e., weight variation, thickness, hardness, and disintegration. Instruments used for different analyses included digital weighing balance, hardness apparatus, vernier caliper, and disintegration tester. Different brands of levothyroxine were purchased from the different community pharmacies for physicochemical analysis and performed physiochemical tests with the comparison of BP and USP specifications. The physicochemical properties of different marketed brands of levothyroxine were performed through digital weighing balance, hardness apparatus, vernier caliper, and disintegration tester. The weight variation is performed using digital weighing balance. First, we determined the parent drug, i.e., Synthroid .0833; however, the rest of the drugs including Eltroxin, thyroxin, and thyronorm are 0.170, 0.146, and 0.1043. The thickness was measured using vernier caliper, and the calculated values of Synthroid, Eltroxin, thyroxine, and thyronorm were 0.0640, 0.410, 0.0847, and 0.1106. The hardness was measured using hardness tester, and the calculated values for synthroid, Eltroxin, thyroxine, and thyronorm were 3.5400, 3.8300, 3.3700, 3.6800. The disintegration was measured with the disintegration tester, and the calculated values of Synthroid, Eltroxin, thyroxine, and thyronorm were 4 min;10 seconds, 1 min, 2 min; 48 seconds and 1 minutes; 43 seconds. Physicochemical properties of all four brands of levothyroxine showed slight differences within the range of BP and USP. This research compared the physicochemical properties of different marketed available brands of levothyroxine with those of a parent company in Karachi, Pakistan. Drug release investigation and bioequivalence should be performed in the near future for more authenticity and prescription confidence.
Title: Comparative Assessment of the Physicochemical Properties of Different Brands of Levothyroxine
Description:
Levothyroxine is an oral form of drug that is used for hypothyroidism disorder.
Hypothyroidism disorder is a condition in which the gland does not produce enough thyroid hormones for the body to perform its functions effectively.
In the commercial market, various brands of levothyroxine are available that are frequently prescribed for hypothyroidism.
In this study, we determined the comparative assessment of physicochemical properties of different brands of marketed available levothyroxine oral tablets in Karachi, Pakistan.
In this study, we evaluated the pharmaceutical equivalency of different marketed brands of levothyroxine by using QC parameters, i.
e.
, weight variation, thickness, hardness, and disintegration.
Instruments used for different analyses included digital weighing balance, hardness apparatus, vernier caliper, and disintegration tester.
Different brands of levothyroxine were purchased from the different community pharmacies for physicochemical analysis and performed physiochemical tests with the comparison of BP and USP specifications.
The physicochemical properties of different marketed brands of levothyroxine were performed through digital weighing balance, hardness apparatus, vernier caliper, and disintegration tester.
The weight variation is performed using digital weighing balance.
First, we determined the parent drug, i.
e.
, Synthroid .
0833; however, the rest of the drugs including Eltroxin, thyroxin, and thyronorm are 0.
170, 0.
146, and 0.
1043.
The thickness was measured using vernier caliper, and the calculated values of Synthroid, Eltroxin, thyroxine, and thyronorm were 0.
0640, 0.
410, 0.
0847, and 0.
1106.
The hardness was measured using hardness tester, and the calculated values for synthroid, Eltroxin, thyroxine, and thyronorm were 3.
5400, 3.
8300, 3.
3700, 3.
6800.
The disintegration was measured with the disintegration tester, and the calculated values of Synthroid, Eltroxin, thyroxine, and thyronorm were 4 min;10 seconds, 1 min, 2 min; 48 seconds and 1 minutes; 43 seconds.
Physicochemical properties of all four brands of levothyroxine showed slight differences within the range of BP and USP.
This research compared the physicochemical properties of different marketed available brands of levothyroxine with those of a parent company in Karachi, Pakistan.
Drug release investigation and bioequivalence should be performed in the near future for more authenticity and prescription confidence.
Related Results
Primerjalna književnost na prelomu tisočletja
Primerjalna književnost na prelomu tisočletja
In a comprehensive and at times critical manner, this volume seeks to shed light on the development of events in Western (i.e., European and North American) comparative literature ...
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
Abstract
Myxedema coma is a medical emergency with a mortality rate of 30–50%. It is a commonly missed diagnosis and can lead to multiple cardiovascular complication...
Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine
Liver Stiffness in Obese Hypothyroid Patients Taking Levothyroxine
Background and Objectives: Thyroid dysfunction is associated with non-alcoholic fatty liver disease, but its role in the progression of liver damage in obese patients remains uncle...
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During Relapses
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During Relapses
Abstract
Introduction:
Levothyroxine treatment for thyroid hormone disorders, alongside standard Nephrotic Syndrome therapy dur...
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During Relapses
A Retrospective Study of Children with Frequently Relapsing Nephrotic Syndrome Using Levothyroxine Added to Steroids During Relapses
Abstract
Introduction:
Levothyroxine treatment for thyroid hormone disorders, alongside standard Nephrotic Syndrome therapy dur...
Use of thyroid hormones in relation to pregnancy: a Danish nationwide cohort study
Use of thyroid hormones in relation to pregnancy: a Danish nationwide cohort study
AbstractObjectiveTo determine the rate of exposure of pregnant women to levothyroxine and to assess changes in these rates before, during and after pregnancy.DesignRegister‐based c...
THYROID STIMULATING HORMONE EVALUATION BETWEEN THREE AND FOUR WEEKS OF LEVOTHYROXINE WITHDRAWAL IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
THYROID STIMULATING HORMONE EVALUATION BETWEEN THREE AND FOUR WEEKS OF LEVOTHYROXINE WITHDRAWAL IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
Most patients with differentiated thyroid cancer (DTC) would require radioactive iodine (RAI) ablation therapy with I-131. Before RAI ablation therapy, levothyroxine is withheld fo...
Detection and Characterization of an Unknown Impurity in Levothyroxine Sodium Tablets by UHPLC, LC/MS, MS/MS and MS/MS/MS
Detection and Characterization of an Unknown Impurity in Levothyroxine Sodium Tablets by UHPLC, LC/MS, MS/MS and MS/MS/MS
Impurities in the active ingredient of a drug are very important for the quality and reliability of the finished product. Therefore, the identification of these impurities constitu...

